PMID: 16508404Mar 2, 2006Paper

Levosimendan, a new inotropic and vasodilator agent

Anesthesiology
Wolfgang G Toller, Christian Stranz

Abstract

Several clinical studies suggest substantial limitations of currently available positive inotropic substances, including beta1-adrenoceptor agonists and phosphodiesterase III inhibitors in the short- and long-term treatment of heart failure. The reasons for these detrimental effects are related to the mechanism of action of these drugs, including increases in intracellular Ca2+ with subsequent increases in myocardial oxygen demand and arrhythmogenesis. Levosimendan, a myofilament Ca2+ sensitizer with inotropic effects, increases myocardial performance without substantial changes in oxygen consumption and with neutral effects on heart rhythm. In addition, levosimendan has vasodilatory effects that are achieved by stimulation of adenosine triphosphate-dependent potassium channels. This action may be of specific interest in the setting of myocardial ischemia. To date, levosimendan is approved in 31 countries worldwide, and more patients with heart failure have participated in randomized controlled trials with levosimendan than with any other intravenous inotropic agent.

References

Aug 1, 1988·Clinical Pharmacokinetics·F V Shammas, K Dickstein
Jul 1, 1983·The American Journal of Physiology·A Fabiato
May 1, 1995·Journal of Cardiovascular Pharmacology·H HaikalaI B Lindén
Jan 1, 1994·European Journal of Clinical Pharmacology·J LillebergM S Nieminen
Sep 1, 1995·Journal of Molecular and Cellular Cardiology·H HaikalaI B Lindén
Jan 1, 1996·European Journal of Clinical Pharmacology·S AntilaE P Sandell
Jul 1, 1996·Journal of Cardiovascular Pharmacology·M F McGoughD C Warltier
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Feb 1, 1997·Journal of Cardiothoracic and Vascular Anesthesia·M F McGoughD C Warltier
Feb 5, 1998·European Journal of Pharmacology·M K Lancaster, S J Cook
May 21, 1998·Journal of Cardiovascular Pharmacology·N GruhnJ Aldershvile
Apr 12, 2000·Circulation·R J HajjarJ K Gwathmey
Sep 12, 2000·European Journal of Pharmacology·P M JanssenG Hasenfuss

❮ Previous
Next ❯

Citations

Nov 13, 2008·General Thoracic and Cardiovascular Surgery·Ferit CicekciogluSalih Fehmi Katircioglu
Nov 13, 2008·General Thoracic and Cardiovascular Surgery·Ferit CicekciogluS Fehmi Katircioglu
Jan 17, 2012·Chemical Communications : Chem Comm·Maitane FernándezDolores Badía
May 23, 2009·British Journal of Anaesthesia·N MongardonM Singer
Nov 29, 2007·Critical Care Medicine·Peter Smetana, Alexander Geppert
Feb 15, 2008·Critical Care Medicine·Miguel TavaresAlexandre Mebazaa
Sep 14, 2006·Current Opinion in Pediatrics·David S Cooper, Mark A Nichter
Jan 8, 2010·Regional Anesthesia and Pain Medicine·Juha AittomäkiPer H Rosenberg
Mar 12, 2009·Journal of Cardiovascular Pharmacology·Markku S NieminenZoltán Papp
Jun 10, 2011·Critical Care : the Official Journal of the Critical Care Forum·Ritesh Maharaj, Victoria Metaxa
Mar 21, 2013·Critical Care : the Official Journal of the Critical Care Forum·Fabio GuarracinoMichael R Pinsky
Dec 25, 2010·Critical Care : the Official Journal of the Critical Care Forum·Andrea MorelliMartin Westphal
Mar 23, 2007·Anesthesia and Analgesia·Stefan G De HertPhilippe J Van der Linden
Nov 13, 2013·Cardiovascular Journal of Africa·Ozgur ErsoyFehmi Katircioglu
Mar 22, 2014·Wiener klinische Wochenschrift·Stjepan BarisinIgor Rudez
Jan 16, 2008·Current Opinion in Anaesthesiology·Sylvia Archan, Wolfgang Toller
Apr 30, 2008·Current Opinion in Anaesthesiology·Bernardo Bollen PintoMartin Westphal
Jul 27, 2010·Critical Care Medicine·Sebastian RehbergMartin Westphal
Sep 20, 2011·Critical Care Medicine·Andreas LehmannFalk-Udo Sack
Jan 26, 2012·European Journal of Anaesthesiology·Kamen P Valchanov, Joseph E Arrowsmith
Nov 8, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jing ZhangYu-Qing Chen
Jan 12, 2016·Expert Opinion on Emerging Drugs·Nicholas HemingDjillali Annane
Jul 12, 2008·Expert Opinion on Investigational Drugs·John T ParissisDimitrios T Kremastinos
Mar 17, 2007·Annals of Medicine·Lasse Lehtonen, Pentti Põder
Mar 6, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Sebastian C TumeRonald A Bronicki
Apr 26, 2008·Journal of Cardiac Surgery·Ozgur ErsoyS Fehmi Katircioglu
Aug 18, 2009·Acta Anaesthesiologica Scandinavica·C MetzschL Algotsson
Jun 7, 2015·The International Journal of Cardiovascular Imaging·S TreskatschM Sander
Dec 18, 2015·Journal of Cardiovascular Pharmacology·Thomas Krarup HillgaardJens Erik Nielsen-Kudsk
Apr 25, 2007·Journal of Pharmacological Sciences·Oguzhan Yildiz
Jun 6, 2015·Critical Reviews in Food Science and Nutrition·Kumar RanganathanNadanasabapathi Shanmugam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.